Related Experiment Video
Updated: Jul 9, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Health care costs of cardiovascular disease in China: a machine learning-based cross-sectional study
Mengjie Lu1,2, Hong Gao3, Chenshu Shi2
1School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Insights
High healthcare costs for cardiovascular disease (CVD) in China are linked to older age, male sex, longer hospital stays, and specific conditions like heart failure. Machine learning identified these key cost determinants.
Area of Science:
- Cardiovascular Medicine
- Health Economics
- Medical Informatics
Background:
- Cardiovascular disease (CVD) imposes a significant financial burden on patients, households, and China's healthcare system.
- Understanding the factors driving healthcare cost variations in CVD patients is crucial for financial relief.
Purpose of the Study:
- To identify and rank the primary determinants of healthcare costs in Chinese CVD patients.
- To assess the impact of these determinants on the overall distribution of CVD-related healthcare expenses.
Main Methods:
- Utilized data from 28,213 CVD patients surveyed in 14 tertiary hospitals in China (2018-2020).
- Employed re-centered influence function regression for cost concentration analysis.
- Applied quantile regression forests (a machine learning approach) to pinpoint factors influencing low, median, and high healthcare costs.
Main Results:
- The 10th, 50th, and 90th quantiles of healthcare costs were 6,103 CNY, 18,105 CNY, and 98,637 CNY, respectively.
- Factors associated with higher costs included older age, male sex, longer hospital stays, more comorbidities, complex procedures, and emergency admissions.
- Specific CVD types like cardiomyopathy, heart failure, and stroke were linked to increased healthcare expenditures.
Conclusions:
- Machine learning effectively identifies key determinants of CVD healthcare costs in China.
- Findings can inform policy interventions to mitigate the financial impact of CVD, especially for high-cost patients.
Background:
Cardiovascular disease (CVD) causes substantial financial burden to patients with the condition, their households, and the healthcare system in China. Health care costs for treating patients with CVD vary significantly, but little is known about the factors associated with the cost variation. This study aims to identify and rank key determinants of health care costs in patients with CVD in China and to assess their effects on health care costs.
Methods:
Data were from a survey of patients with CVD from 14 large tertiary grade-A general hospitals in S City, China, between 2018 and 2020. The survey included information on demographic characteristics, health conditions and comorbidities, medical service utilization, and health care costs. We used re-centered influence function regression to examine health care cost concentration, decomposing and estimating the effects of relevant factors on the distribution of costs. We also applied quantile regression forests-a machine learning approach-to identify the key factors for predicting the 10th (low), 50th (median), and 90th (high) quantiles of health care costs associated with CVD treatment.
Results:
Our sample included 28,213 patients with CVD. The 10th, 50th and 90th quantiles of health care cost for patients with CVD were 6,103 CNY, 18,105 CNY, and 98,637 CNY, respectively. Patients with high health care costs were more likely to be older, male, and have a longer length of hospital stay, more comorbidities, more complex medical procedures, and emergency admissions. Higher health care costs were also associated with specific CVD types such as cardiomyopathy, heart failure, and stroke.
Conclusion:
Machine learning methods are useful tools to identify determinants of health care costs for patients with CVD in China. Findings may help improve policymaking to alleviate the financial burden of CVD, particularly among patients with high health care costs.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...